Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Journal of Pharmacokinetics and Biopharmaceutics

Search In Journal Title:

Abbravation: Journal of Pharmacokinetics and Biopharmaceutics

Search In Journal Abbravation:

Publisher

Kluwer Academic Publishers-Plenum Publishers

Search In Publisher:

DOI

10.1016/0010-7824(77)90036-1

Search In DOI:

ISSN

0090-466X

Search In ISSN:
Search In Title Of Papers:

Application of optimal sampling theory to the dete

Authors: Michel Tod Christophe Padoin Kamel Louchahi Brigitte MoreauTod Olivier Petitjean Gerard Perret
Publish Date: 1994/04/01
Volume: 22, Issue: 2, Pages: 129-146
PDF Link

Abstract

Use of optimal sampling theory OST in pharmacokinetic studies allows the number of sampling times to be greatly reduced without loss in parameter estimation precision OST has been applied to the determination of the bioavailability parameters area under the curve AUC maximal concentration Cmax time to reach maximal concentration Tmax elimination halflife T1/2 of metacycline in 16 healthy volunteers Five different models were used to fit the data and to define the optimal sampling times onecompartment firstorder twocompartment firstorder twocompartment zeroorder twocompartment with MichaelisMenten absorption kinetics and a stochastic model The adequacy of these models was first evaluated in a 6subject pilot study Only the stochastic model with zeroorder absorption kinetics was adequate Then bioavailability parameters were estimated in a group of 16 subjects by means of noncompartmental analysis with 19 samples per subject using each optimal sampling schedule based procedure with 6 to 9 samples depending on the model Bias PE and precision RMSE of each bioavailability parameter estimation were calculated by reference to noncompartmental analysis and were satisfactory for the 3 adequate models The most relevant criteria for discrimination of the best model were the coefficient of determination the standard deviation and the mean residual error vs time plot Additional criteria were the number of required sampling times and the coefficient of variation of the estimates In this context the stochastic model was superior and yielded very good estimates of the bioavailability parameters with only 8 samples per subject


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Influence of plasma protein binding kinetics on hepatic clearance assessed from a “tube” model and a “well-stirred” model
  2. Quinidine pharmacokinetics in man: Choice of a disposition model and absolute bioavailability studies
  3. Effect of plasma protein and tissue binding on the time course of drug concentration in plasma
  4. A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients
  5. Linear pharmacokinetic models: Geometric construction to determine transfer and elimination rate constants
  6. Modeling of drug response in individual subjects
  7. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model
  8. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man
  9. Pharmacokinetics and bioavailability of intravenous, oral, and rectal nitrazepam in humans
  10. Estimation of drug binding parameters
  11. Relationship between plasma or serum drug concentration and amount of drug in the body at steady state upon multiple dosing
  12. Pharmacokinetics of teicoplanin in man after intravenous administration
  13. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics
  14. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
  15. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922
  16. Simulation for population analysis of Michaelis-Menten elimination kinetics
  17. Pharmacodynamic modeling of the in vitro vasodilating effects of organic mononitrates

Search Result: